SCHEMBL18992129

SCHEMBL18992129

CC(C)=CCC1=C(O)C(=O)c2cc(Cl)ccc2C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.55
MAPT P10636 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
KDM4E B2RXH2 2/20 0.55
CYP3A4 P08684 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55
TP53 P04637 1/20 0.55
PKM P14618 1/20 0.55
CDC25A P30304 1/20 0.55
CDC25B P30305 1/20 0.55
RPS6KA3 P51812 1/20 0.55
GLO1 Q04760 1/20 0.55
GPR35 Q9HC97 1/20 0.55
S100A4 P26447 2/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24349487 0.84 DHODH (0.56) DHODHMAPTMEN1KMT2AKDM4E
SCHEMBL24348761 0.84 DHODH (0.56) DHODHMAPTMEN1KMT2AKDM4E
SCHEMBL18992123 0.83 DHODH (0.55) DHODHMAPTMEN1KMT2AKDM4E
Lapachol SCHEMBL157255 0.82 DHODH (0.79) DHODHMAPTMEN1KMT2AKDM4E
Lapachol SCHEMBL31492698 0.82 DHODH (0.79) DHODHMAPTMEN1KMT2AKDM4E
SCHEMBL13624923 0.81 DHODH (0.52) DHODHMAPTMEN1KMT2AKDM4E
SCHEMBL9713797 0.80 S100A4 (0.50) DHODHMAPTMEN1KMT2AKDM4E
Lapachol SCHEMBL18769814 0.80 DHODH (0.77) DHODHMAPTMEN1KMT2AKDM4E
Lapachol SCHEMBL3274147 0.80 DHODH (0.77) DHODHMAPTMEN1KMT2AKDM4E
SCHEMBL3279172 0.76 S100A4 (0.67) DHODHS100A4APAF1TDP2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829427-B2 Naphthoquinones, pro-drugs, and methods of use thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-11-10 US disclosed
US-20190071380-A1 NAPHTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-03-07 US disclosed
WO-2017106624-A1 NAPTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829427-B2 Naphthoquinones, pro-drugs, and methods of use thereof NQO1, RECQL, ABCB1 DHODH 667/4885MAPT 3573/4885MEN1 226/4885
US-20190071380-A1 NAPHTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF NQO1, RECQL, ABCB1 DHODH 667/4885MAPT 3573/4885MEN1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.